Skip to main content
OpenTrials
Completed

NCT Number: NCT05701020

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test

Human Papilloma virus is the most common sexual infection in women, which can leads to cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until 65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific knowledge about chronic disease showed negative consequences on quality of life.

However, no study until now has striven to evaluate the consequences of an abnormal pap test on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test have an impact on the sexual functions in women because of the anxiety and psychological consequences of the diagnosis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sexual Dysfunction Epidemiology Genital Diseases Sexual Dysfunction, Physiological Urogenital Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens

Amiens, 80480, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult women with an abnormal pap test.
  • Diagnosis known 4 to 12 weeks before the appointment for colposcopy

Exclusion criteria

  • Cervical cancer
  • Pregnancy

Treatment and study plan

Questionnary

Other

If agreeing to the protocol, ; patients will answered questions about sexual health during the gynecologic consultation

Primary outcomes

  1. % ofpositive response rate at the first question of the questionnaire

    Time frame: 18 months

Secondary outcomes

  1. Number of causes of woman alteration sexual function alteration

    Time frame: 18 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: EVASEF

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 27, 2023
Registry last updated
Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.